莱沃多巴诱导的伪染色细胞瘤
Joana Cardoso1, Ana Silveira1, Sara Duarte1
1Hospital da Horta, Azores, Portugal.
European journal of case reports in internal medicine
|June 12, 2023
概括
伪染色细胞瘤是一种模仿染色细胞瘤的疾病,可能是由levodopa引起的. 这一案例突出了勒沃多巴诱导的伪染色细胞瘤,强调了药物诱导的高血压管理.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 伪染色细胞瘤呈现出类似于染色细胞瘤的症状,包括神经系统性高血压.
- 关键的诊断特征包括正常或中度升高的甲醇胺和甲基氨酸水平,没有瘤原因.
- 通过成像和光学图像来排除染细胞瘤至关重要.
研究的目的:
- 为了描述与莱沃多巴治疗相关的伪染色细胞瘤病例.
- 为了说明勒沃多巴诱导的伪染色细胞瘤的临床和实验室表现.
- 强调在高血压患者中考虑药物副作用的重要性.
主要方法:
- 病例报告是一名患有阳性高血压,头痛,出汗和心的患者.
- 实验室分析显示血和尿液中甲基氨酸水平增加.
- 诊断工作排除了上腺或额外上腺瘤,包括I-123 MIBG扫描.
主要成果:
- 患者的症状开始在开始服用利沃多巴治疗后出现.
- 没有发现高血压的瘤原因的证据.
- 在停止服用利沃多巴后,症状完全消失.
结论:
- 伪染色细胞瘤和真染色细胞瘤在临床和实验室上有相似之处,但有不同的病因.
- 诊断依赖于有异常catecholamine/metanephrine水平的阳性高血压,瘤后排除.
- 利沃多巴是伪染色细胞瘤的潜在原因,特别是与其他影响甲基荷胺代谢的药物结合使用时.
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
356
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
356
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenal Gland Disorders
1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K


